rs386833744
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001042432.2(CLN3):c.988G>T(p.Val330Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V330I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001042432.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN3 | NM_001042432.2 | c.988G>T | p.Val330Phe | missense_variant | Exon 14 of 16 | ENST00000636147.2 | NP_001035897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLN3 | ENST00000636147.2 | c.988G>T | p.Val330Phe | missense_variant | Exon 14 of 16 | 1 | NM_001042432.2 | ENSP00000490105.1 | ||
ENSG00000261832 | ENST00000637378.1 | c.160G>T | p.Val54Phe | missense_variant | Exon 4 of 10 | 5 | ENSP00000490831.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461466Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727022
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis 3 Pathogenic:2
- -
- -
Neuronal ceroid lipofuscinosis Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Val330 amino acid residue in CLN3. Other variant(s) that disrupt this residue have been observed in individuals with CLN3-related conditions (PMID: 28542676), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this variant affects CLN3 protein function (PMID: 19132115). This variant has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 9311735, 22013180). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 56296). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with phenylalanine at codon 330 of the CLN3 protein (p.Val330Phe). The valine residue is highly conserved and there is a small physicochemical difference between valine and phenylalanine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at